104 related articles for article (PubMed ID: 22331176)
1. Rosiglitazone treatment reversed depression- but not psychosis-like behavior of db/db diabetic mice.
Sharma AN; Elased KM; Lucot JB
J Psychopharmacol; 2012 May; 26(5):724-32. PubMed ID: 22331176
[TBL] [Abstract][Full Text] [Related]
2. Antidepressant-like effects of rosiglitazone, a PPARγ agonist, in the rat forced swim and mouse tail suspension tests.
Eissa Ahmed AA; Al-Rasheed NM; Al-Rasheed NM
Behav Pharmacol; 2009 Oct; 20(7):635-42. PubMed ID: 19745723
[TBL] [Abstract][Full Text] [Related]
3. The PPARgamma ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice.
Hwang J; Kleinhenz DJ; Rupnow HL; Campbell AG; Thulé PM; Sutliff RL; Hart CM
Vascul Pharmacol; 2007 Jun; 46(6):456-62. PubMed ID: 17337254
[TBL] [Abstract][Full Text] [Related]
4. Synergistic improvement in insulin resistance with a combination of fenofibrate and rosiglitazone in obese type 2 diabetic mice.
Choi WS; Lee JJ; Kim Y; Kim IS; Zhang WY; Myung CS
Arch Pharm Res; 2011 Apr; 34(4):615-24. PubMed ID: 21544727
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.
Yamanaka M; Itakura Y; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
Diabetes Obes Metab; 2007 Nov; 9(6):879-88. PubMed ID: 17924870
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of Hypericum perforatum on depression and anxiety in a type 2 diabetic rat model.
Husain GM; Chatterjee SS; Singh PN; Kumar V
Acta Pol Pharm; 2011; 68(6):913-8. PubMed ID: 22125957
[TBL] [Abstract][Full Text] [Related]
7. Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone.
Wargent E; Stocker C; Augstein P; Heinke P; Meyer A; Hoffmann T; Subramanian A; Sennitt MV; Demuth HU; Arch JR; Cawthorne MA
Diabetes Obes Metab; 2005 Mar; 7(2):170-81. PubMed ID: 15715890
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant-like effect of pioglitazone in the forced swimming test in mice: the role of PPAR-gamma receptor and nitric oxide pathway.
Sadaghiani MS; Javadi-Paydar M; Gharedaghi MH; Fard YY; Dehpour AR
Behav Brain Res; 2011 Oct; 224(2):336-43. PubMed ID: 21704657
[TBL] [Abstract][Full Text] [Related]
9. Neurobehavioral deficits in db/db diabetic mice.
Sharma AN; Elased KM; Garrett TL; Lucot JB
Physiol Behav; 2010 Oct; 101(3):381-8. PubMed ID: 20637218
[TBL] [Abstract][Full Text] [Related]
10. The anti-diabetic effects of ethanol extract from two variants of Artemisia princeps Pampanini in C57BL/KsJ-db/db mice.
Jung UJ; Baek NI; Chung HG; Bang MH; Yoo JS; Jeong TS; Lee KT; Kang YJ; Lee MK; Kim HJ; Yeo JY; Choi MS
Food Chem Toxicol; 2007 Oct; 45(10):2022-9. PubMed ID: 17574717
[TBL] [Abstract][Full Text] [Related]
11. Supplementation of a novel microbial biopolymer, PGB1, from new Enterobacter sp. BL-2 delays the deterioration of type 2 diabetic mice.
Yeo J; Lee YH; Jeon SM; Jung UJ; Lee MK; Jung YM; Choi MS
J Microbiol Biotechnol; 2007 Dec; 17(12):1983-90. PubMed ID: 18167446
[TBL] [Abstract][Full Text] [Related]
12. Enteroinsular axis of db/db mice and efficacy of dipeptidyl peptidase IV inhibition.
Nagakura T; Yasuda N; Yamazaki K; Ikuta H; Tanaka I
Metabolism; 2003 Jan; 52(1):81-6. PubMed ID: 12524666
[TBL] [Abstract][Full Text] [Related]
13. Combination of dipeptidylpeptidase IV inhibitor and low dose thiazolidinedione: preclinical efficacy and safety in db/db mice.
Roy S; Khanna V; Mittra S; Dhar A; Singh S; Mahajan DC; Priyadarsiny P; Davis JA; Sattigeri J; Saini KS; Bansal VS
Life Sci; 2007 Jun; 81(1):72-9. PubMed ID: 17532347
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant effects of insulin in streptozotocin induced diabetic mice: Modulation of brain serotonin system.
Gupta D; Kurhe Y; Radhakrishnan M
Physiol Behav; 2014 Apr; 129():73-8. PubMed ID: 24582678
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614.
Minoura H; Takeshita S; Ita M; Hirosumi J; Mabuchi M; Kawamura I; Nakajima S; Nakayama O; Kayakiri H; Oku T; Ohkubo-Suzuki A; Fukagawa M; Kojo H; Hanioka K; Yamasaki N; Imoto T; Kobayashi Y; Mutoh S
Eur J Pharmacol; 2004 Jun; 494(2-3):273-81. PubMed ID: 15212984
[TBL] [Abstract][Full Text] [Related]
16. alpha-Tocopherol administration produces an antidepressant-like effect in predictive animal models of depression.
Lobato KR; Cardoso CC; Binfaré RW; Budni J; Wagner CL; Brocardo PS; de Souza LF; Brocardo C; Flesch S; Freitas AE; Dafré AL; Rodrigues AL
Behav Brain Res; 2010 Jun; 209(2):249-59. PubMed ID: 20144659
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice.
Wang Q; Brubaker PL
Diabetologia; 2002 Sep; 45(9):1263-73. PubMed ID: 12242459
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes.
Phillips JW; Barringhaus KG; Sanders JM; Yang Z; Chen M; Hesselbacher S; Czarnik AC; Ley K; Nadler J; Sarembock IJ
Circulation; 2003 Oct; 108(16):1994-9. PubMed ID: 14517165
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
Miyazaki Y; DeFronzo RA
Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone attenuates the cognitive deficits induced by high fat diet feeding in rats.
Pathan AR; Gaikwad AB; Viswanad B; Ramarao P
Eur J Pharmacol; 2008 Jul; 589(1-3):176-9. PubMed ID: 18602098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
